Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Blood Typing01:10

Blood Typing

Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...
The ABO Blood Group01:12

The ABO Blood Group

The ABO blood group system is a critical element of transfusion medicine, essential for determining blood compatibility in transfusions and organ transplants. It is based on specific antigens, or agglutinogens, present on the surface of red blood cells (RBCs) and corresponding antibodies, or agglutinins, in the blood plasma.
Antigens in the ABO Blood Group System
Antigens are substances that can trigger an immune response, leading to the production of antibodies. In the ABO blood group system,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Successful perinatal management of hydrops fetalis due to hemolytic disease associated with D-- maternal phenotype.

Journal of perinatology : official journal of the California Perinatal Association·2002
Same author

Exchange transfusion with red blood cells preserved in adenine clears a child of severe falciparum malaria.

Annals of clinical and laboratory science·1997
Same author

Serum and CSF levels of IL-2, sIL-2R, TNF-alpha, and IL-1 beta in chronic progressive multiple sclerosis: expected lack of clinical utility.

Neurology·1991
Same author

IgG subclasses in human chronic schistosomiasis: over-production of schistosome-specific and non-specific IgG4.

Clinical and experimental immunology·1990
Same author

Dot-ELISA for serodiagnosis of human infections due to Western equine encephalitis virus.

Journal of virological methods·1989
Same author

Dot-enzyme-linked immunosorbent assay (dot-ELISA) for the rapid diagnosis of human fascioliasis.

The Journal of parasitology·1989

Related Experiment Video

Updated: Jun 19, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

Overt immediate hemolytic transfusion reaction attributable to anti-Wr(a).

F N Boctor1

  • 1Geisinger Medical Center, Danville, PA 17822, USA.

Immunohematology
|October 23, 2009
PubMed
Summary

Anti-Wr(a) antibodies can cause transfusion reactions. A patient experienced an acute hemolytic transfusion reaction after receiving Wr(a+) red blood cells, highlighting the clinical significance of this antibody.

Area of Science:

  • Immunology
  • Transfusion Medicine
  • Hematology

Background:

  • The Wr(a) antigen is a low-prevalence red blood cell (RBC) antigen.
  • Anti-Wr(a) antibodies are found in about 1% of healthy blood donors.
  • These antibodies have been associated with varying degrees of hemolysis in transfusion reactions and hemolytic disease of the newborn (HDN).

Observation:

  • This case report details an acute overt hemolytic transfusion reaction.
  • The patient had pre-existing anti-Wr(a) antibodies in their serum.
  • The reaction occurred after transfusion with a Wr(a+) RBC component.

Findings:

  • The presence of anti-Wr(a) antibodies in a recipient led to a clinically significant hemolytic transfusion reaction.
  • The transfusion of Wr(a+) RBCs to a patient with anti-Wr(a) antibodies resulted in an acute overt hemolytic event.

More Related Videos

Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols
11:31

Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols

Published on: January 2, 2013

Related Experiment Videos

Last Updated: Jun 19, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols
11:31

Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols

Published on: January 2, 2013

Implications:

  • Clinicians should consider screening for anti-Wr(a) antibodies in patients with unexplained hemolytic reactions.
  • Careful donor-recipient matching for the Wr(a) antigen is crucial for patients with anti-Wr(a) antibodies to prevent transfusion reactions.
  • This case underscores the importance of recognizing and managing antibodies to low-prevalence antigens in transfusion medicine.